aTyr Pharma Inc (LIFE) - Financial and Strategic SWOT Analysis Review



ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. Its ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropilin-2 receptor harness immune engagement in interstitial lung diseases and other immune-mediated diseases. It also concentrates on research and development of extracellular functionality of tRNA synthetases. ATyr Pharma also develops drugs for cancer, inflammation, neurodegenerative diseases, and metabolic disorders. The company collaborates with research institutions for its research and development activities. ATyr Pharma is headquartered in San Diego, California, the US.

aTyr Pharma Inc Key Recent Developments

May 12,2020: aTyr Pharma announces first quarter 2020 results and provides corporate update on ATYR1923 clinical trials in pulmonary sarcoidosis and covid-19
Mar 26,2020: aTyr Pharma announces fourth quarter and full year 2019 results and provides corporate update
Mar 24,2020: aTyr Pharma and its Hong Kong subsidiary, Pangu BioPharma, announce government grant to fund bispecific antibody development platform
Mar 17,2020: Leading cancer researcher Dr. Arthur M. Mercurio joins aTyr as Scientific Advisor
Nov 14,2019: aTyr Pharma announces third quarter 2019 results and provides corporate update

This comprehensive SWOT profile of aTyr Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of aTyr Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

aTyr Pharma Inc - Key Information
aTyr Pharma Inc - Overview
aTyr Pharma Inc - Key Employees
aTyr Pharma Inc - Key Employee Biographies
aTyr Pharma Inc - Key Operational Heads
aTyr Pharma Inc - Major Products and Services
aTyr Pharma Inc - History
aTyr Pharma Inc - Company Statement
aTyr Pharma Inc - Locations And Subsidiaries
aTyr Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

aTyr Pharma Inc - Business Description
aTyr Pharma Inc - Corporate Strategy
aTyr Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
aTyr Pharma Inc - Strengths
aTyr Pharma Inc - Weaknesses
aTyr Pharma Inc - Opportunities
aTyr Pharma Inc - Threats
aTyr Pharma Inc - Key Competitors

Section 3 - Company Financial Performance Charts

aTyr Pharma Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



aTyr Pharma Inc, Key Information
aTyr Pharma Inc, Key Ratios
aTyr Pharma Inc, Share Data
aTyr Pharma Inc, Major Products and Services
aTyr Pharma Inc, History
aTyr Pharma Inc, Key Employees
aTyr Pharma Inc, Key Employee Biographies
aTyr Pharma Inc, Key Operational Heads
aTyr Pharma Inc, Other Locations
aTyr Pharma Inc, Subsidiaries
aTyr Pharma Inc, Key Competitors
aTyr Pharma Inc, SWOT Analysis
aTyr Pharma Inc, Ratios based on current share price
aTyr Pharma Inc, Annual Ratios
aTyr Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



aTyr Pharma Inc, Performance Chart
aTyr Pharma Inc, Ratio Charts
 


aTyr Pharma Inc (LIFE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The companys resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies

USD 250 View Report

Ocuphire Pharma Inc (OCUP) - Financial and Strategic SWOT Analysis Review

Ocuphire Pharma Inc (Ocuphire Pharma), formerly Rexahn Pharmaceuticals Inc, is an ophthalmic biopharmaceutical company that develops and commercializes medicines to treat eye disorders. It is investigating Nyxol, a preservative-free ophthalmic

USD 300 View Report

PDL BioPharma Inc - Strategic SWOT Analysis Review

PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available